ENDOCRINE EFFECTS OF COVID 19: DIFFICULTIES IN THE MANAGEMENT OF ENDOCRINE DISORDERS FROM INDIVIDUAL TO SOCIETIES

Area of Science:

• Endocrinology
• Infectious Diseases
• Public Health

Background:

• The COVID-19 pandemic has profoundly affected healthcare systems globally.
• Patients with endocrine comorbidities (diabetes, metabolic syndrome, pituitary, thyroid, adrenal disorders) face increased risks and unique management challenges during the pandemic.

Purpose of the Study:

• To outline specific recommendations for managing endocrine disorders during the COVID-19 pandemic.
• To address the unique challenges posed by endocrine comorbidities in COVID-19 patients.
• To guide endocrine professionals in adapting patient care strategies.

Main Methods:

• Review and synthesis of European expert recommendations for endocrine disorder management.
• Emphasis on epidemiological safety measures, including delaying non-emergency admissions.
• Integration of telemedicine for routine follow-up appointments.

Main Results:

• Adherence to safety protocols and telemedicine is crucial for managing endocrine patients.
• Special attention is required for adrenal disorders and the metabolic effects of corticosteroids, especially in diabetic patients.
• Non-emergency surgeries for thyroid, pituitary, and adrenal conditions are postponed; emergency laparoscopic surgeries require enhanced personal protective equipment (PPE).

Conclusions:

• A coordinated, multidisciplinary approach is essential for the effective management of endocrine patients during the COVID-19 pandemic.
• Adapting clinical practices to incorporate safety measures and telemedicine is vital.
• Careful consideration of corticosteroid use and its metabolic impact is necessary.